4//SEC Filing
ORBIMED ADVISORS LLC 4
Accession 0000947871-21-000788
CIK 0001522860other
Filed
Jul 20, 8:00 PM ET
Accepted
Jul 21, 5:30 PM ET
Size
13.2 KB
Accession
0000947871-21-000788
Insider Transaction Report
Form 4
ORBIMED ADVISORS LLC
Director10% Owner
Transactions
- Purchase
Common Stock
2021-07-19$14.00/sh+357,143$5,000,002→ 1,677,361 total(indirect: See Footnotes) - Purchase
Common Stock
2021-07-19$14.00/sh+714,285$9,999,990→ 4,872,025 total(indirect: See Footnotes)
Holdings
- 4,022(indirect: See Footnotes)
Common Stock
Orbimed ROF II LLC
Director10% Owner
Transactions
- Purchase
Common Stock
2021-07-19$14.00/sh+357,143$5,000,002→ 1,677,361 total(indirect: See Footnotes) - Purchase
Common Stock
2021-07-19$14.00/sh+714,285$9,999,990→ 4,872,025 total(indirect: See Footnotes)
Holdings
- 4,022(indirect: See Footnotes)
Common Stock
OrbiMed Capital GP IV LLC
Director10% Owner
Transactions
- Purchase
Common Stock
2021-07-19$14.00/sh+714,285$9,999,990→ 4,872,025 total(indirect: See Footnotes) - Purchase
Common Stock
2021-07-19$14.00/sh+357,143$5,000,002→ 1,677,361 total(indirect: See Footnotes)
Holdings
- 4,022(indirect: See Footnotes)
Common Stock
Footnotes (5)
- [F1]These shares of the Issuer's common stock were purchased in the Issuer's underwritten public offering.
- [F2]These shares of the Issuer's common stock are held of record by OrbiMed Private Investments IV, LP ("OPI IV"). OrbiMed Capital GP IV LLC ("GP IV") is the general partner of OPI IV, and OrbiMed Advisors LLC ("OrbiMed Advisors"), a registered investment adviser under the Investment Advisors Act of 1940, as amended, is the managing member of GP IV. OrbiMed Advisors and GP IV exercise investment and voting power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the Shares held by OPI IV.
- [F3]These shares of the Issuer's common stock are held of record by OrbiMed Royalty Opportunities II, LP ("ORO II"). OrbiMed ROF II LLC ("ROF II") is the general partner of ORO II, and OrbiMed Advisors is the managing member of ORO II. OrbiMed Advisors and ROF II exercise investment and voting power through a management committee comprised of Carl L. Gordon, Sven H. Borho, and W. Carter Neild, each of whom disclaims beneficial ownership of the Shares held by ORO II.
- [F4]This report on Form 4 is jointly filed by GP IV, ROF II, and OrbiMed Advisors. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), except to the extent of its pecuniary interest therein, if any. OrbiMed Advisors and GP IV have designated David Bonita ("Bonita"), a member of OrbiMed Advisors, to serve on the Issuer's board of directors. This report shall not be deemed an admission that any of the Reporting Persons, or Bonita, is a beneficial owner of such securities for the purposes of Section 16 of the Exchange Act, or for any other purposes.
- [F5]Represents shares of the Issuer's common stock received by Bonita for service on the Issuer's board of directors. Pursuant to an agreement with OrbiMed Advisors and GP IV, Bonita is obligated to transfer these securities, or the economic benefit thereof, to OrbiMed Advisors and GP IV, which will in turn ensure that such securities or economic benefits are provided to OPI IV.
Documents
Issuer
Acutus Medical, Inc.
CIK 0001522860
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001055951
Filing Metadata
- Form type
- 4
- Filed
- Jul 20, 8:00 PM ET
- Accepted
- Jul 21, 5:30 PM ET
- Size
- 13.2 KB